Medical Communications

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …

The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …

The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …

Israeli biopharmaceutical firm is celebrating the approval in the US of Consensi, a combo of the calcium channel blocker amlodipine …

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

Roche has announced that it will no longer seek to develop its treatment for spinal muscular atrophy (SMA), olesoxime, after …

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …

Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …

The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …

Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …

The new June edition of Pharmafocus is now available to read online.

Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …

Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities. Otsuka Pharmaceutical Development …